Evidence Details for KAL1
Basic Information Top
Gene Symbol: | KAL1 ( ADMLX,HHA,KAL,KALIG-1,KMS ) |
---|---|
Gene Full Name: | Kallmann syndrome 1 sequence |
Band: | Xp22.32 |
Quick Links | Entrez ID:3730; OMIM: 308700; Uniprot ID:KALM_HUMAN; ENSEMBL ID: ENSG00000011201; HGNC ID: |
Relate to Another Database: | SFARIGene; denovo-db |
Sequences Top
>KAL1|3730|nucleotide
ATGGTGCCCGGGGTGCCCGGCGCGGTCCTGACCCTCTGCCTCTGGCTGGCGGCCTCCAGCGGCTGCCTGGCGGCCGGCCCCGGCGCGGCTGCTGCGCGGCGGCTG
GACGAGTCGCTGTCTGCCGGGAGCGTCCAGCGCGCTCGCTGCGCCTCCAGGTGCCTGAGCCTGCAGATCACTCGCATCTCCGCCTTCTTCCAGCACTTCCAGAAC
AATGGTTCCCTGGTTTGGTGCCAGAATCACAAGCAATGTTCTAAGTGCCTGGAGCCCTGCAAGGAATCAGGGGACCTGAGGAAACACCAGTGCCAAAGCTTTTGT
GAGCCTCTCTTCCCCAAGAAGAGCTACGAATGCTTGACCAGCTGTGAGTTCCTCAAATACATCCTGTTGGTGAAGCAGGGGGACTGTCCGGCTCCTGAGAAAGCC
AGTGGATTTGCGGCCGCCTGTGTTGAAAGCTGCGAAGTTGACAATGAGTGCTCTGGGGTGAAGAAATGTTGTTCGAATGGGTGTGGACACACCTGTCAAGTACCC
AAGACTCTGTACAAAGGTGTCCCCCTGAAGCCCAGAAAAGAGTTACGATTTACAGAACTGCAGTCTGGACAGCTGGAGGTTAAGTGGTCCTCGAAATTCAATATT
TCTATTGAGCCTGTGATCTATGTGGTACAAAGAAGATGGAATTATGGAATCCATCCTAGCGAAGATGACGCCACTCACTGGCAGACAGTGGCCCAGACCACAGAC
GAGCGAGTTCAACTGACTGACATAAGACCCAGCCGATGGTACCAGTTTCGAGTGGCTGCTGTGAATGTGCATGGAACTCGAGGCTTCACTGCCCCCAGCAAACAC
TTCCGTTCTTCCAAAGATCCATCTGCCCCACCAGCACCGGCTAACCTCCGGCTGGCCAACTCCACCGTCAACAGTGATGGGAGTGTGACCGTCACTATAGTTTGG
GATCTCCCCGAGGAGCCGGACATCCCTGTGCATCATTACAAGGTCTTTTGGAGCTGGATGGTCAGCAGTAAGTCTCTTGTCCCAACAAAGAAGAAGCGGAGAAAG
ACTACGGATGGGTTTCAAAATTCTGTGATCCTGGAGAAACTCCAGCCAGACTGTGACTATGTTGTGGAATTGCAAGCCATAACGTACTGGGGACAGACACGGCTG
Show »
ATGGTGCCCGGGGTGCCCGGCGCGGTCCTGACCCTCTGCCTCTGGCTGGCGGCCTCCAGCGGCTGCCTGGCGGCCGGCCCCGGCGCGGCTGCTGCGCGGCGGCTG
GACGAGTCGCTGTCTGCCGGGAGCGTCCAGCGCGCTCGCTGCGCCTCCAGGTGCCTGAGCCTGCAGATCACTCGCATCTCCGCCTTCTTCCAGCACTTCCAGAAC
AATGGTTCCCTGGTTTGGTGCCAGAATCACAAGCAATGTTCTAAGTGCCTGGAGCCCTGCAAGGAATCAGGGGACCTGAGGAAACACCAGTGCCAAAGCTTTTGT
GAGCCTCTCTTCCCCAAGAAGAGCTACGAATGCTTGACCAGCTGTGAGTTCCTCAAATACATCCTGTTGGTGAAGCAGGGGGACTGTCCGGCTCCTGAGAAAGCC
AGTGGATTTGCGGCCGCCTGTGTTGAAAGCTGCGAAGTTGACAATGAGTGCTCTGGGGTGAAGAAATGTTGTTCGAATGGGTGTGGACACACCTGTCAAGTACCC
AAGACTCTGTACAAAGGTGTCCCCCTGAAGCCCAGAAAAGAGTTACGATTTACAGAACTGCAGTCTGGACAGCTGGAGGTTAAGTGGTCCTCGAAATTCAATATT
TCTATTGAGCCTGTGATCTATGTGGTACAAAGAAGATGGAATTATGGAATCCATCCTAGCGAAGATGACGCCACTCACTGGCAGACAGTGGCCCAGACCACAGAC
GAGCGAGTTCAACTGACTGACATAAGACCCAGCCGATGGTACCAGTTTCGAGTGGCTGCTGTGAATGTGCATGGAACTCGAGGCTTCACTGCCCCCAGCAAACAC
TTCCGTTCTTCCAAAGATCCATCTGCCCCACCAGCACCGGCTAACCTCCGGCTGGCCAACTCCACCGTCAACAGTGATGGGAGTGTGACCGTCACTATAGTTTGG
GATCTCCCCGAGGAGCCGGACATCCCTGTGCATCATTACAAGGTCTTTTGGAGCTGGATGGTCAGCAGTAAGTCTCTTGTCCCAACAAAGAAGAAGCGGAGAAAG
ACTACGGATGGGTTTCAAAATTCTGTGATCCTGGAGAAACTCCAGCCAGACTGTGACTATGTTGTGGAATTGCAAGCCATAACGTACTGGGGACAGACACGGCTG
Show »
>KAL1|3730|protein
MVPGVPGAVLTLCLWLAASSGCLAAGPGAAAARRLDESLSAGSVQRARCASRCLSLQITRISAFFQHFQNNGSLVWCQNHKQCSKCLEPCKESGDLRKHQCQSFC
EPLFPKKSYECLTSCEFLKYILLVKQGDCPAPEKASGFAAACVESCEVDNECSGVKKCCSNGCGHTCQVPKTLYKGVPLKPRKELRFTELQSGQLEVKWSSKFNI
SIEPVIYVVQRRWNYGIHPSEDDATHWQTVAQTTDERVQLTDIRPSRWYQFRVAAVNVHGTRGFTAPSKHFRSSKDPSAPPAPANLRLANSTVNSDGSVTVTIVW
DLPEEPDIPVHHYKVFWSWMVSSKSLVPTKKKRRKTTDGFQNSVILEKLQPDCDYVVELQAITYWGQTRLKSAKVSLHFTSTHATNNKEQLVKTRKGGIQTQLPF
QRRRPTRPLEVGAPFYQDGQLQVKVYWKKTEDPTVNRYHVRWFPEACAHNRTTGSEASSGMTHENYIILQDLSFSCKYKVTVQPIRPKSHSKAEAVFFTTPPCSA
Show »
MVPGVPGAVLTLCLWLAASSGCLAAGPGAAAARRLDESLSAGSVQRARCASRCLSLQITRISAFFQHFQNNGSLVWCQNHKQCSKCLEPCKESGDLRKHQCQSFC
EPLFPKKSYECLTSCEFLKYILLVKQGDCPAPEKASGFAAACVESCEVDNECSGVKKCCSNGCGHTCQVPKTLYKGVPLKPRKELRFTELQSGQLEVKWSSKFNI
SIEPVIYVVQRRWNYGIHPSEDDATHWQTVAQTTDERVQLTDIRPSRWYQFRVAAVNVHGTRGFTAPSKHFRSSKDPSAPPAPANLRLANSTVNSDGSVTVTIVW
DLPEEPDIPVHHYKVFWSWMVSSKSLVPTKKKRRKTTDGFQNSVILEKLQPDCDYVVELQAITYWGQTRLKSAKVSLHFTSTHATNNKEQLVKTRKGGIQTQLPF
QRRRPTRPLEVGAPFYQDGQLQVKVYWKKTEDPTVNRYHVRWFPEACAHNRTTGSEASSGMTHENYIILQDLSFSCKYKVTVQPIRPKSHSKAEAVFFTTPPCSA
Show »
Evidence summary Top
Click the link of the category-specific score to view different category of evidences. The categories without any evidences are hidden by default.
Evidences | Syndromic Gene | GWAS | CNV | Linkage | Association | Expression | NGS de novo | NGS Mosaic | NGS Other | Low-Scale Gene Studies | Total |
---|---|---|---|---|---|---|---|---|---|---|---|
Score (No. of Studies) | No | 0 (0) | 1 (3) | 0 (0) | 0 (0) | 0 (0) | 0 (1) | 0 (0) | 0 (0) | 0 (0) | 2 (4) |
Syndromic Autism Gene Top
Genome-Wide Association Studies(By Ethnic Group) Top
CNV Studies Top
Reference | Source | Method | ADI-R | ADOS | Diagnosis | Family | Individual | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total | Simplex | Multiplex | Control | Affected | Control | Total | ||||||
Thomas, 1999 | - | FISH | autism | - | - | - | - | 3 | - | 3 | ||
Vazna, 2010 | Czech | aCGH | ASD | - | - | - | - | 1 | - | 1 | ||
Edens, 2011 | Honduras | aCGH | autism | - | - | - | - | 1 | - | 1 | ||
Edens, 2011 | Austria | FISH, aCGH | autism | - | - | - | - | 1 | - | 1 |
Linkage Studies Top
Low Scale Association Studies (by Ethnic Group) Top
Large Scale Expression Studies Top
NGS de novo Mutation Studies Top
Reference | Case Number | Family Number | de novo Number | Title |
---|---|---|---|---|
Jiang YH, 2013 | - | 32 | 39 | Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome seque |
NGS Mosaic SNV Studies Top
NGS Other Studies Top
Reference | Source | Platform | ADI-R | ADOS | Diagnosis | Family | Affected | Validation Method | ||
---|---|---|---|---|---|---|---|---|---|---|
Total | Simplex | Multiplex | ||||||||
Nava C, 2012 | France | - | ASD | 12 | - | 12 | - | - |
Low Scale Gene Studies Top
Contact Us if you are an author of a study regarding this gene and do not find your study in this table or find errors in the representation of your study details.